Trials / Unknown
UnknownNCT04564365
The Contemporary Role of Beta Blockers in Patients With Acute Myocardial Infarction
Influence of Beta-Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Chongqing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The use of beta blockers after acute myocardial infarction is a core component of drug therapy, but evidence is primarily derived from patients who did not receive reperfusion therapy and secondary prophylaxis.In contemporary times, the prognostic value of beta blockers in patients with acute myocardial infarction has been questioned, particularly in patients without reduced heart failure/ejection fraction after acute myocardial infarction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | beta-blocker | To investigate the relationship between the use of beta blockers and prognosis in patients with normal ejection fraction after acute myocardial infarction |
Timeline
- Start date
- 2019-06-30
- Primary completion
- 2021-11-25
- Completion
- 2021-12-25
- First posted
- 2020-09-25
- Last updated
- 2021-11-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04564365. Inclusion in this directory is not an endorsement.